Germany was one of the first European countries to join the growing club of countries legalizing at least the use of medical cannabis. It legalized medical cannabis in the spring of 2017. Since then, cannabis has been available in pharmacies on prescription.
Recreational use is authorized from April 1, 2024. The has embarked on the legal regulation of cannabis in 2022 and could open its first legal cannabis sales as early as 2025. The first elements of the legalization of cannabis in Germany were presented by the German Minister of Health.
A National Cannabis Agency oversees national cannabis production, which will be replaced by the importation of medical cannabis.
Legal
Recreational cannabis is legal in Germany. Medical use is authorized under certain conditions.
Which countries in Europe have legalized cannabis?«Das Gras, the German word for weed, has undergone some legislative changes in recent years.
Germany's cannabis laws were amended on March 10, 2017, when the country legalized the prescription of cannabis to seriously ill patients, even if other treatment options are available. An amendment to the narcotics law (Betäubungsmittelgesetz) has enacted this change, which also includes the assumption of the cost of treatment by patients' health insurance.
The legalization of medical use is the first move on cannabis since a 1994 court ruling that ruled out the application of criminal penalties provided the quantity held is «small», as specified by the various German states.
The country has decided to legalize cannabis in 2022. By the time the bill has been written, put to the vote, passed and the production and distribution of cannabis to adults put in place, the first Cannabis Clubs will open in July 2024. Retail stores could follow in 2025.
Recreational cannabis is now legal in the city-state of Berlin, and medical cannabis is permitted under German marijuana laws.
A survey of the existing medical market in early 2018 reported 13,000 applications submitted by patients after the medical use legislation came into force in March 2017. By 2021, they number nearly 50,000.
To keep up with demand, Germany has opened applications for growers and has selected 3 companies who, from mid-2021, will ensure the regular supply of part of the German medical market, up to the point of replacing imports.
The Federal Institute for Drugs and Medical Devices has set up a cannabis agency in accordance with the 1961 United Nations Single Convention on Narcotic Drugs, which stipulates that 'a member state must establish or designate such a public body as soon as it is planned to cultivate cannabis in the state in question for non-industrial purposes» Werner Knöss, Ph.D., is the designated head of the German cannabis agency within the Federal Institute for Drugs and Medical Devices.
Main regulatory body: Federal Institute for Drugs and Medical Devices
Sub-agency: Federal Opium Agency
Contact for «Exceptional authorizations to purchase cannabis for medical purposes».
Consumption by adults is legal but restricted near schools and other places where children are present.
Medical cannabis is prescribed by doctors to seriously ill patients and distributed by pharmacies. No special permit is required to obtain medical marijuana in Germany. However, doctors must believe that cannabis will be beneficial in treating the illness or symptoms.
In most cases, insurance companies cover or reimburse patients for medical marijuana.
The manufacture, purchase and sale of hemp oil and CBD with a THC content of less than 0.2 % are legal in Germany.
The sale of CBD flowers is periodically called into question by the German justice system, which considers that even at -0.2% THC, they could be intoxicating. This does not prevent Germany from having numerous CBD shops selling German and European CBD flowers in addition to the classic derivative products.
Sanity Group a annoncé un nouveau partenariat de distribution avec l’opérateur suisse du cannabis Astrasana Holding AG, renforçant ainsi sa présence sur le marché suisse, qui...
This week, Berlin is set to once again become one of the main centers of gravity of the European cannabis market. In the space of a few days, the German capital will concentrate...
The U.S. Food and Drug Administration (FDA) has granted «breakthrough therapy» designation to VER-01, a cannabis-derived treatment developed by the...
Dutch medical cannabis producer Bedrocan has announced the launch of a pharmaceutical-grade cannabis concentrate derived from the renowned Bedrocan® strain. Scheduled for...
Germany once again demonstrates the scale of its medical cannabis market. According to figures recently published by the Federal Institute for Drugs and Medical Devices (BfArM),...
Canadian cannabis giant Canopy Growth has announced the relaunch of its flagship Tweed brand on the German medical cannabis market, marking the...
Germany's Federal Commissioner for Drugs, Hendrik Streeck, has become the first prominent member of the conservative CDU party to publicly support...
The German government is currently facing widespread criticism after proposing to remove medical cannabis flowers from the list of...
Germany imported 50,539 kg of cannabis flowers for medical or scientific use in the first quarter of 2026 (Q1 2026), according...
Curaleaf has finalized the acquisition of the remaining shares it did not already own in Four 20 Pharma, a leading German producer and distributor of medical cannabis. Announced...
A new research project in Neuss, near Düsseldorf, may soon be testing regulated cannabis retailing under the framework established by the...
An unexpected discovery at the Museum für Naturkunde Berlin could shake up what we thought we knew about the ancient history of cannabis. By cataloguing a botanical collection and...
On April 1, 2024, the Cannabis Consumption Act (KCanG) came into force in Germany. It legalized the possession and cultivation...
The medical cannabis markets in the UK and Germany both more than doubled in size throughout 2025, confirming a...
The debate surrounding the legalization of cannabis in Germany continues to divide the political landscape, but one key voice is calling for caution in the face of...
Germany continues to consolidate its position as Europe's leading market for medical cannabis. According to the Federal Institute for Drugs and Medical Devices (BfArM), the country has...
Canadian cannabis producer Organigram Global has announced its intention to acquire Germany's «second largest» medical cannabis company, Sanity Group, in...
The Die Linke parliamentary group has tabled a motion in the Bundestag calling for a thorough reform of current legislation and full legalization,...
Initial findings from a study into the impact of partial cannabis legalization in Germany show no short-term increase in consumption or...
For the first time, a Bavarian cannabis-growing association has legally distributed cannabis to its members, marking a symbolic step forward in one of the...
